As a note; I contacted Steve Rubin today. This was in regards to the yesterday’s Cramer Quote (see below).
Steve said that OPKO was not aware of any invite from CNBC Cramer. But they will follow up.
CRAMER CNBC Mad Money 5/21/2021:
CNBC Jim Cramer - OPKO Health: “It’s problematic because you have BioReference, and that’s calming down because of the pandemic, and then you have all these other great things that they’ve got that they’ve got to start talking about, but they don’t want to come on the show, so I have to say, ‘pass.’”
I think at one time JCramer was quite enamored of Frost and when things weren't so great he tread lightly and later when Frost wouldn't come on at his request and the SEC matter occurred.... Cramer could no longer afford to give PF a pass.
PS: It's a crock for Rubin to say that OPK doesn't know Cramer wanted FROST on though Cramer seemed happy to have Jon Cohen on......is he saying NOW that Cohen is also refusing to come on?
I find that hard to believe. But absolutely PF did ignore Cramer's very specific inviteS a few years ago. I think one thing that needs to happen is to get Rubin off all these other boards of directors and have him focus on what should be #1--- OPKO. IMHO
What can Frost possibly say Rayaldee didn’t take off 4 k was a bust Clarios was a bust, all of strategic investments weren’t so strategic what can he say he’s better off not going the show. Don’t forget Varubi the inhaler the prostate shrinking drug I forgot what that one was called.I wouldn’t be surprised if the stock went down to 1.18 again. Oh that’s right royalties by the time we get that I’m sure Frost will figure out how to blow that. If it wasn’t for the Coronavirus and Cohen the stock would be below a dollar. I’d like somebody to tell me what would it take to move this stock up .We all know management knows how to move it down.
i agree w/ the last few posts: the fact they wouldn't take free publicity - and note they have not been at a single conference in over 6 months when their competitors have been at multiple, shows they have nothing good to say. It's been almost a month since the last rayaldee-covid update - why not say something like "its coming" unless its gonna slip again. And if Rayaldee this quarter has swung back to 40% growth (which would still do nothing but put it back on where it was supposed to be a year ago) they could come out publicly and say that. Cohen had no problem when trying to get business to say they had MSG when they don't for covid-testing, so why not say Rayaldee drop was covid-related and with cases at all time low its now growing back at the pace it was supposed to as an update? And update that the core lab business, now that covid-19 has declined, has swung back to growth? Why not play up their 20% insured member growth? Lots you could say, if it any of it was true, unless they can't say it. Btw: don't forget they would ask about the diluted share offering, which we now know was not an incentive for any deal and the only answer to that can be negative, so they don't want to answer it. That cramer quote is pretty bad news.